Search Videos and More
Attentive Care Across the Lifespan
The Guerin Family Congenital Heart Program in the Smidt Heart Institute is one of the world’s very few entities offering the full spectrum of care for congenital heart disease patients, all in one place, with continuity in the medical and surgical teams from infancy to adulthood.From Minimally Invasive to Robotic: Heralding the Future of Lung Transplantation
Lung transplantation at Cedars-Sinai—a multidisciplinary collaboration between the Smidt Heart Institute and the Comprehensive Transplant Center—is characterized by innovations that are changing the landscape of cardiothoracic surgery and care.Turning Today’s Discoveries Into Tomorrow’s Standard of Care
The Smidt Heart Institute cares for a high volume of patients who present with some of the most complex heart rhythm disorders, referred from around the nation.More Opportunities and Leading-Edge Solutions for Successful Transplants
Our carefully developed desensitization protocol, coupled with numerous trials investigating novel pharmaceutical options, allows patients with even 100% circulating antibody presence to undergo a heart transplant with minimal risk of acute and chronic rejection.A Unique Path Forward for Every Patient
No matter their heart condition, treatment history, complications or risk factors, every patient sent to the Smidt Heart Institute Advanced Heart Disease Program for evaluation or treatment can access an unrivaled range of clinical experience and technical expertise.'Broken Heart' Syndrome Is on the Rise in Women
Smidt Heart Institute Study Shows Cases of Takotsubo Syndrome, the Rare Heart-Brain Disorder, Are Increasing in Middle-Aged and Older WomenMediterranean Diet Linked to Lower Preeclampsia Risk
Smidt Heart Institute Investigators Found That Women Who Conceived While Following a Mediterranean Diet Had Lower Risk of Developing Adverse Pregnancy OutcomesContinuity of Care Makes Future Brighter for Young Heart Patient
During Lara Borda's first seven years of life, her parents would listen to her heartbeat every night as part of their bedtime ritual.What to Know About the Recently Approved Alzheimer’s Drug
Leqembi, Newly Approved by FDA, Shows Potential Benefit for Patients With Early-Stage Disease, But Availability Will Take Time, Says Cedars-Sinai ExpertFaculty Publications: Jan. 5 - Jan.12
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Jan. 5 - Jan.12.Cedars-Sinai Streamlines Lung Cancer Screening
New Cedars-Sinai Cancer Program Aims to Boost Screening Rates for Patients, Simplify Follow-Up Care, and Serve More CommunitiesMapping Endometriosis: A Vast Cellular Atlas Is Created
Cedars-Sinai investigators produced data from 400,000 patient cells to better understand the disease.